10.00
price up icon0.30%   0.03
after-market Handel nachbörslich: 10.02 0.02 +0.20%
loading
Schlusskurs vom Vortag:
$9.97
Offen:
$9.96
24-Stunden-Volumen:
838.20K
Relative Volume:
0.69
Marktkapitalisierung:
$383.89M
Einnahmen:
$127.70M
Nettoeinkommen (Verlust:
$-121.25M
KGV:
-3.1746
EPS:
-3.15
Netto-Cashflow:
$-120.32M
1W Leistung:
-0.89%
1M Leistung:
-0.20%
6M Leistung:
+30.21%
1J Leistung:
-33.38%
1-Tages-Spanne:
Value
$9.945
$10.03
1-Wochen-Bereich:
Value
$9.93
$10.17
52-Wochen-Spanne:
Value
$4.80
$18.13

Iteos Therapeutics Inc Stock (ITOS) Company Profile

Name
Firmenname
Iteos Therapeutics Inc
Name
Telefon
857-204-4583
Name
Adresse
321 ARSENAL STREET, WATERTOWN
Name
Mitarbeiter
173
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-05
Name
Neueste SEC-Einreichungen
Name
ITOS's Discussions on Twitter

Vergleichen Sie ITOS mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ITOS
Iteos Therapeutics Inc
10.00 383.89M 127.70M -121.25M -120.32M -3.15
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
452.16 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
534.91 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
322.06 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
542.47 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.16 28.51B 3.81B -644.79M -669.77M -6.24

Iteos Therapeutics Inc Stock (ITOS) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-05-28 Herabstufung Wedbush Outperform → Neutral
2025-05-28 Herabstufung Wells Fargo Overweight → Equal Weight
2025-05-14 Herabstufung H.C. Wainwright Buy → Neutral
2025-05-14 Herabstufung Leerink Partners Outperform → Market Perform
2025-05-13 Herabstufung JP Morgan Overweight → Neutral
2024-08-13 Eingeleitet Wells Fargo Overweight
2021-05-05 Eingeleitet H.C. Wainwright Buy
2020-10-08 Eingeleitet Robert W. Baird Outperform
2020-08-18 Eingeleitet JP Morgan Overweight
2020-08-18 Eingeleitet Piper Sandler Overweight
2020-08-18 Eingeleitet SVB Leerink Outperform
2020-08-18 Eingeleitet Wedbush Outperform
Alle ansehen

Iteos Therapeutics Inc Aktie (ITOS) Neueste Nachrichten

pulisher
Jun 17, 2025

iTeos Therapeutics Holds Annual Stockholders Meeting - TipRanks

Jun 17, 2025
pulisher
Jun 17, 2025

Stock Performance Spotlight: ITeos Therapeutics Inc (ITOS) Ends the Day at 10.10, Down by -0.69 - DWinneX

Jun 17, 2025
pulisher
Jun 16, 2025

Layoff Tracker: Gilead Cuts 36 Employees in California - BioSpace

Jun 16, 2025
pulisher
Jun 15, 2025

Learn to Evaluate (ITOS) using the Charts - news.stocktradersdaily.com

Jun 15, 2025
pulisher
Jun 12, 2025

ITeos Therapeutics Insider Sold Shares Worth $1,048,264, According to a Recent SEC Filing - MarketScreener

Jun 12, 2025
pulisher
Jun 12, 2025

Bank of America Corp DE Decreases Position in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

Brokerages Set iTeos Therapeutics, Inc. (NASDAQ:ITOS) PT at $15.86 - Defense World

Jun 11, 2025
pulisher
Jun 09, 2025

ITeos Therapeutics Insider Sold Shares Worth $1,592,520, According to a Recent SEC Filing - marketscreener.com

Jun 09, 2025
pulisher
Jun 07, 2025

Director David Hallal Sells 114,682 Shares of ITeos Therapeutics Inc (ITOS) - GuruFocus

Jun 07, 2025
pulisher
Jun 07, 2025

Squarepoint Ops LLC Sells 18,686 Shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World

Jun 07, 2025
pulisher
Jun 06, 2025

iTeos Therapeutics CEO Michel Detheux sells $1.59m in stock By Investing.com - Investing.com India

Jun 06, 2025
pulisher
Jun 06, 2025

iTeos Therapeutics CEO Michel Detheux sells $1.59m in stock - Investing.com

Jun 06, 2025
pulisher
Jun 06, 2025

iTeos Therapeutics Executives Sell Significant Shares - TradingView

Jun 06, 2025
pulisher
Jun 06, 2025

Nuveen Asset Management LLC Trims Holdings in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

iteos therapeutics announces board resignation - Investing.com

Jun 05, 2025
pulisher
Jun 05, 2025

iteos therapeutics announces board resignation By Investing.com - Investing.com UK

Jun 05, 2025
pulisher
Jun 05, 2025

Tim Van Hauwermeiren Resigns from iTeos Board - TipRanks

Jun 05, 2025
pulisher
Jun 04, 2025

Deutsche Bank AG Sells 14,418 Shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World

Jun 04, 2025
pulisher
Jun 03, 2025

More bad news in biotech: Watertown cancer firm iTeos shutting down - The Boston Globe

Jun 03, 2025
pulisher
Jun 02, 2025

Long Term Trading Analysis for (ITOS) - news.stocktradersdaily.com

Jun 02, 2025
pulisher
Jun 02, 2025

Q2 EPS Forecast for iTeos Therapeutics Decreased by Analyst - Defense World

Jun 02, 2025
pulisher
Jun 01, 2025

iTeos Therapeutics, Inc. (NASDAQ:ITOS) Position Increased by Ameriprise Financial Inc. - Defense World

Jun 01, 2025
pulisher
May 31, 2025

iTeos Therapeutics (ITOS) Upgraded to Buy: Here's What You Should Know - MSN

May 31, 2025
pulisher
May 31, 2025

Wedbush Lowers Earnings Estimates for iTeos Therapeutics - Defense World

May 31, 2025
pulisher
May 30, 2025

Rx Rundown: Novartis, iTeos Therapeutics, Moderna and more - Medical Marketing and Media

May 30, 2025
pulisher
May 30, 2025

iTeos Therapeutics Stock Jumps Following Operational Closure Announcement - MSN

May 30, 2025
pulisher
May 29, 2025

All Over For iTeos But Applause For Plan To Return Cash Fast - insights.citeline.com

May 29, 2025
pulisher
May 29, 2025

iTeos to shut down operations after TIGIT setback and GSK exit - The Pharma Letter

May 29, 2025
pulisher
May 29, 2025

iTeos Therapeutics (NASDAQ:ITOS) Receives “Equal Weight” Rating from Wells Fargo & Company - Defense World

May 29, 2025
pulisher
May 29, 2025

iTeos Therapeutics to wind down operations, explore asset sales By Investing.com - Investing.com South Africa

May 29, 2025
pulisher
May 29, 2025

iTeos Therapeutics (NASDAQ:ITOS) Lowered to “Neutral” Rating by Wedbush - Defense World

May 29, 2025
pulisher
May 28, 2025

Wedbush cuts iTeos stock rating, raises PT to $12 from $10 - Investing.com Canada

May 28, 2025
pulisher
May 28, 2025

Drug developer iTeos to shut down operations after cancer therapy setback - 1470 & 100.3 WMBD

May 28, 2025
pulisher
May 28, 2025

Cancer drugmaker iTeos to shut down - BioPharma Dive

May 28, 2025
pulisher
May 28, 2025

iTeos Therapeutics To Wind Down Operations, Explores Asset Sale: Retail Believes It’s ‘Worth More Selling It Off’ - Investing.com India

May 28, 2025
pulisher
May 28, 2025

iTeos Therapeutics stock surges on wind-down news By Investing.com - Investing.com Canada

May 28, 2025
pulisher
May 28, 2025

Watertown immuno-oncology biotech winds down operations - The Business Journals

May 28, 2025
pulisher
May 28, 2025

iTeos Therapeutics (ITOS) Downgraded by Wells Fargo with Revised Price Target | ITOS Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

iTeos Therapeutics (ITOS) Faces Downgrade Amid Operational Changes | ITOS Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

ITeos Therapeutics (ITOS) Sees Downgrade and Target Price Cut | - GuruFocus

May 28, 2025
pulisher
May 28, 2025

ITeos Therapeutics (ITOS) Sees Downgrade and Target Price Cut | ITOS Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

iTeos Therapeutics stock surges on wind-down news - Investing.com

May 28, 2025
pulisher
May 28, 2025

ITeos Therapeutics (ITOS) Receives Analyst Downgrade from Wedbus - GuruFocus

May 28, 2025
pulisher
May 28, 2025

iTeos Therapeutics (ITOS) Downgraded as Company Plans Operationa - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Wedbush Downgrades iTeos Therapeutics (ITOS) Rating to Neutral | - GuruFocus

May 28, 2025
pulisher
May 28, 2025

I Teos Therapeutics Inc Expected Severance Costs Of $21.8 Million To $24.7 Million - marketscreener.com

May 28, 2025
pulisher
May 28, 2025

ITeos Therapeutics (ITOS) Receives Analyst Downgrade from Wedbush | ITOS Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Wedbush Downgrades iTeos Therapeutics to Neutral From Outperform, Adjusts Price Target to $12 From $10 - marketscreener.com

May 28, 2025
pulisher
May 28, 2025

iTeos Therapeutics (ITOS) to Cease Operations and Explore Strate - GuruFocus

May 28, 2025
pulisher
May 28, 2025

iTeos Therapeutics (ITOS) Shares Surge on Plans to Cease Operati - GuruFocus

May 28, 2025
pulisher
May 28, 2025

iTeos Therapeutics (ITOS) to Wind Down Operations, Focus on Shar - GuruFocus

May 28, 2025

Finanzdaten der Iteos Therapeutics Inc-Aktie (ITOS)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Iteos Therapeutics Inc-Aktie (ITOS) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Detheux Michel
Chief Executive Officer
Jun 09 '25
Option Exercise
4.30
43,882
188,693
43,882
Detheux Michel
Chief Executive Officer
Jun 10 '25
Option Exercise
4.30
26,400
113,520
153,903
Detheux Michel
Chief Executive Officer
Jun 09 '25
Option Exercise
4.30
8,400
36,120
144,303
Detheux Michel
Chief Executive Officer
Jun 09 '25
Sale
10.03
43,882
440,136
0
Detheux Michel
Chief Executive Officer
Jun 10 '25
Sale
10.02
43,883
439,708
0
Detheux Michel
Chief Executive Officer
Jun 09 '25
Sale
10.03
8,400
84,252
135,903
Detheux Michel
Chief Executive Officer
Jun 10 '25
Sale
10.02
8,400
84,168
135,903
$20.74
price up icon 0.39%
$35.88
price down icon 0.42%
$21.20
price down icon 0.38%
$97.62
price down icon 3.00%
$107.51
price up icon 0.98%
biotechnology ONC
$245.16
price up icon 1.28%
Kapitalisierung:     |  Volumen (24h):